The problem with MSB at that stage is: this is taking too long
about 1.00 was the raised as Covid trial.
the process is so ling that now 2 vaccines with 95% effective become available in next 3 months and they will start with exactly the most vilnareble.
the size of potential market for ARDS - Covid is x% less every single day we postpone the final approval.
i feel is a shame how FDA is acting because if 1% better they should announce and authorised under compassionate usage and go ahead with trial.
the only reason acceptable( in my opinion) if they found the rem-l effectiveness is not good at all ( what could invite ask and how mt sinai trial was so good?)
every day we are closing to 1- 1.50 plus or 1-1.50 less. Really hard game ( and scary)
good luck if i are holding
CATO
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-362
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |